In silico and ex vivo drug screening identifies dasatinib as a targeted therapy for T-ALL

  • Saara Laukkanen (Speaker)

    Activity: Talk or presentation › Conference presentation

    Description

    Contributors: Laukkanen Saara, Lohi Olli
    Period7 Mar 2017
    Event titleNOPHO LL Biology Working Group Meeting
    Event typeOther
    Degree of RecognitionInternational